Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists

Journal of Neurochemistry

Volumn 69, Issue 2, 1997, Pages 845-850

  Sharma, Rajendra K ^a,b   Wang, Jerry H ^a,c   Wu, Z ^a,d  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Ca2+; Ca2+ blockers; Calmodulin; Calmodulin dependent phosphodiesterase; Dihydropyridine calcium antagonists

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM ION; CALMODULIN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; DIHYDROPYRIDINE DERIVATIVE; FELODIPINE; NICARDIPINE;

ARTICLE; ENZYME ACTIVE SITE; ENZYME MECHANISM; ENZYME POLYMORPHISM; ENZYME SUBUNIT; PRIORITY JOURNAL; SECOND MESSENGER; TISSUE SPECIFICITY;

EID: 0030800037     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69020845.x     Document Type: Article

References (33)

1. Beavo J. (1995) Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75, 725-743.
2. Beavo J. A., Conti M., and Heaslip R. J. (1994) Multiple cyclic nucleotide phosphodiesterase. Mol. Pharmacol. 75, 399-405.
3. Bostrom S.-L., Ljun B., Mardh D., Forsen S., and Thulin E. (1981) Interaction of the antihypertensive drug felodipine with calmodulin. Nature (Lond.) 292, 777-778.
4. Bostrom S.-L., Westerlund C., Rochester S., and Vogel H. J (1988) Binding of a dihydropyridine felodipine-analogue to calmodulin and related calcium binding proteins. Biochem. Pharmacol. 37, 3723-3728.
5. Cornish-Bowden A. (1979) Fundamentals of Enzyme Kinetics. Butterworths, London.
6. DeQuattro V. (1994) Individualization of therapy for hypertension in the 1990's: the role of calcium antagonists. Clin. Exp. Hypertens. 16, 853-864.
7. Epstein P. M., Fiss K., Hachison R., and Andrenyak M. (1982) Interaction of calcium antagonists with cyclic AMP phosphodiesterase and calmodulin. Biochem. Biophys. Res. Commun. 105, 1142-1149.
8. Florio V. A., Sonnenburg W. K., Johnson R., Kwak K. S., Jensen G. S., Walsh K. A., and Beavo J. A. (1994) Phosphorylation of the 61-kDa calmodulin-stimulated cyclic nucleotide phosphodiesterase at serine 120 reduces its affinity for calmodulin. Biochemistry 33, 8948-8954.
9. Hansen R. S., and Beavo J. A. (1986) Differential recognition of calmodulin-enzyme complexes by a conformation-specific anticalmodulin monoclonal antibody. J. Biol. Chem. 261, 14636-14645.
10. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 264, 10884-10887.
11. Johnson J. D. (1983) Allosteric interactions among drug binding sites on calmodulin. Biochem. Biophys. Res. Commun. 112, 787-793.
12. Ljung B. (1985) Vascular selectivity of felodipine. Drugs 29, 46-58.
13. Mayer D. (1995) Pharmacokinetics and pharmacodynamics of calcium channel blockers. Vnitr. Lek. 41, 164-166.
14. Mills J. S. and Jonhson J. D. (1985) Metal ions as allosteric regulators of calmodulin. J. Biol. Chem. 260, 15100-15105.
15. Minocherhomjee A. M. and Roufogalis B. D. (1984) Antagonism of calmodulin and phosphodiesterase by nifedipine and related calcium entry blockers. Cell Calcium 5, 57-63.
16. Movsesian M. A., Swain A. L., and Adelstein R. S. (1984) Inhibition of turkey gizzard myosin light chain kinase activity by dihydropyridine calcium antagonists. Biochem. Pharmacol. 33, 3759-3764.
17. Mutus B., Karuppiah N., Sharma R. K., and MacManus J. P. (1985) The differential stimulation of brain and heart cyclic-AMP phosphodiesterase by oncomodulin. Biochem. Biophys. Res. Commun. 131, 500-506.
18. Ronea-Testoni S., Hrelia S., Hakim G., and Rossi C. A. (1985) Interaction of smooth muscle relaxant drugs with calmodulin and cyclic nucleotide phosphodiesterase. Experientia 41, 75-76.
19. Sharma R. K. (1990) Purification and characterization of novel calmodulin-binding protein from cardiac muscle. J. Biol. Chem. 265, 1152-1157.
20. Sharma R. K. (1991) Phosphorylation and characterization of bovine heart calmodulin-dependent phosphodiesterase. Biochemistry 30, 5963-5968.
21. 2+/calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1), in The Handbook of Immunology and Pharmacology - Phosphodiesterase Inhibitors (Dent G., Robe K., and Schudt C., eds), pp. 65-79. Academic Press, London.
22. Sharma R. K. and Kalra J. (1994a) Characterization of calmodulin-dependent cyclic nucleotide phosphodiesterase isozymes. Biochem. J. 299, 97-100.
23. Sharma R. K. and Kalra J. (1994b) Ginsenosides are potent and selective inhibitors of some calmodulin-dependent phosphodiesterase isozymes. Biochemistry 32, 4975-4978.
24. Sharma R. K. and Wang J. H. (1985) Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase. Proc. Natl. Acad. Sci. USA 82, 2603-2607.
25. Sharma R. K. and Wang J. H. (1986) Regulation of 63 kDa subunit containing isozyme of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase by a calmodulin-dependent protein kinase. J. Biol. Chem. 261, 1322-1328.
26. Sharma R. K., Adachi A. H., Adachi K., and Wang J. H. (1984) Demonstration of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme by monoclonal antibodies. J. Biol. Chem. 259, 9248-9254.
27. Sharma R. K., Mooibroek M. J., and Wang J. H. (1988) Calmodulin-stimulated cyclic nucleotide phosphodiesterase isozymes, in The Molecular Aspects of Cellular Regulation, Vol. 5 (Cohen P. and Klee C. B., eds), pp. 265-295. Elsevier, Amsterdam.
28. Silver P. J., Ambrose J. M., Michalak R. J., and Dachiw J. (1984) Effect of felodipine, nitrendipine and W-7 on arterial myosin phosphorylation, actin-myosin interactions and contraction. Eur. J. Pharmacol. 102, 417-424.
29. Thompson W. J., Terasaki W. L., Epstein P. M., and Strada S. J. (1979) Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv. Cyclic Nucleotide Res. 10, 69-92.
30. Walsh M. P., Sutherland C., and Scott-Woo G. C. (1988) Effects of felodipine (a dihydropyridine calcium channel blocker) and analogues on calmodulin-dependent enzymes. Biochem. Pharmacol. 37, 1569-1580.
31. Wang J. H., Sharma R. K., Mooibroek M. J. (1990) Calmodulin-stimulated cyclic nucleotide phosphodiesterase, in The Molecular Pharmacology of Cell Regulation, Vol. 5 (Beavo J. and Houslay M. D., eds), pp. 19-59. John Wiley, Chichester, England.
32. Wu Z., Sharma R. K., and Wang J. H. (1992) Catalytic and regulatory properties of CaM-stimulated phosphodiesterase isozyme. Adv. Second Messenger Phosphoprotein Res. 25, 29-43.
33. Zhang G. Y., Wang J. H., and Sharma R. K. (1993) Purification and characterization of bovine brain calmodulin-dependent protein kinase II. The significance of autophosphorylation in the regulation of 63 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme. Mol. Cell. Biochem. 122, 159-169.